Assessment of variations in control of asthma over time

被引:48
作者
Combescure, C
Chanez, P
Saint-Pierre, P
Daurès, JP
Proudhon, H
Godard, P
机构
[1] Inst Univ Rech Clin, Lab Biostat, F-34093 Montpellier, France
[2] CHU Montpellier, Hop Arnaud Villeneuve, Serv Pneumol, Montpellier, France
[3] Hop Enfants La Timone, Lab Biostat, Marseille, France
关键词
asthma; control states; Markov model; severity;
D O I
10.1183/09031936.03.00081102
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Control and severity of asthma are two different but complementary concepts. The severity of asthma could influence the control over time. The aim of this study was to demonstrate this relationship. A total 365 patients with persistent asthma (severity) were enrolled and followed-up prospectively. Data were analysed using a continuous time homogeneous Markov model of the natural history of asthma. Control of asthma was defined according to three health states which were qualified: optimal, suboptimal and unacceptable control (states 1, 2 and 3). Transition forces (denoted lambda(ij) from state i to state j) and transition probabilities between control states were assessed and the results stratified by asthma severity were compared. Models were validated by comparing expected and observed numbers of patients in the different states. Transition probabilities stabilised between 100-250 days and more rapidly in patients with mild-to-moderate asthma. Patients with mild-to-moderate asthma in suboptimal or unacceptable control had a high probability of transition directly to optimal control. Patients with severe asthma had a tendency to remain in unacceptable control. A Markov model is a useful tool to model the control of asthma over time. Severity modified clearly the health states. It could be used to compare the performance of different approaches to asthma management.
引用
收藏
页码:298 / 304
页数:7
相关论文
共 22 条
  • [1] [Anonymous], ENCY STAT SCI
  • [2] Is overall asthma control being achieved? A hypothesis-generating study
    Bateman, ED
    Bousquet, J
    Braunstein, GL
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (04) : 589 - 595
  • [3] IDENTIFICATION OF LYMPHOCYTES-T, MACROPHAGES, AND ACTIVATED EOSINOPHILS IN THE BRONCHIAL-MUCOSA IN INTRINSIC ASTHMA - RELATIONSHIP TO SYMPTOMS AND BRONCHIAL RESPONSIVENESS
    BENTLEY, AM
    MENZ, G
    STORZ, C
    ROBINSON, DS
    BRADLEY, B
    JEFFERY, PK
    DURHAM, SR
    KAY, AB
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02): : 500 - 506
  • [4] Markov model and markers of small cell lung cancer:: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis
    Boher, JM
    Pujol, JL
    Grenier, J
    Daurès, JP
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1419 - 1427
  • [5] Boudemaghe T, 2000, REV EPIDEMIOL SANTE, V48, P249
  • [6] Boulet LP, 1999, CAN MED ASSOC J, V161, pS1
  • [7] EOSINOPHILIC INFLAMMATION IN ASTHMA
    BOUSQUET, J
    CHANEZ, P
    LACOSTE, JY
    BARNEON, G
    GHAVANIAN, N
    ENANDER, I
    VENGE, P
    AHLSTEDT, S
    SIMONYLAFONTAINE, J
    GODARD, P
    MICHEL, FB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) : 1033 - 1039
  • [8] ENHANCED ALVEOLAR CELL LUMINOL-DEPENDENT CHEMILUMINESCENCE IN ASTHMA
    CLUZEL, M
    DAMON, M
    CHANEZ, P
    BOUSQUET, J
    DEPAULET, AC
    MICHEL, FB
    GODARD, P
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 80 (02) : 195 - 201
  • [9] Asthma control versus asthma severity
    Cockcroft, DW
    Swystun, VA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) : 1016 - 1018
  • [10] MULTISTATE MARKOV-MODELS FOR ANALYZING INCOMPLETE DISEASE HISTORY DATA WITH ILLUSTRATIONS FOR HIV DISEASE
    GENTLEMAN, RC
    LAWLESS, JF
    LINDSEY, JC
    YAN, P
    [J]. STATISTICS IN MEDICINE, 1994, 13 (08) : 805 - 821